• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

信任与之有何关系?重新审视阿片类药物使用合同。

What's trust got to do with it? Revisiting opioid contracts.

作者信息

Buchman Daniel Z, Ho Anita

机构信息

Interdisciplinary Studies Graduate Program and National Core for Neuroethics, The University of British Columbia, Vancouver, British Columbia, Canada.

W. Maurice Young Centre for Applied Ethics, The University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

J Med Ethics. 2014 Oct;40(10):673-7. doi: 10.1136/medethics-2013-101320. Epub 2013 Sep 7.

DOI:10.1136/medethics-2013-101320
PMID:24014642
Abstract

Prescription opioid abuse (POA) is an escalating clinical and public health problem. Physician worries about iatrogenic addiction and whether patients are 'drug seeking', 'abusing' and 'diverting' prescription opioids exist against a backdrop of professional and legal consequences of prescribing that have created a climate of distrust in chronic pain management. One attempt to circumvent these worries is the use of opioid contracts that outline conditions patients must agree to in order to receive opioids. Opioid contracts have received some scholarly attention, with trust and trustworthiness identified as key values and virtues. However, few articles have provided a critical account of trust and trustworthiness in this context, particularly when there exists disagreement about their role in terms of enhancing or detracting from the patient-physician relationship. This paper argues that opioid contracts represent a misleading appeal to patient-physician trust. Assuming the patient is untrustworthy may wrongfully undermine the credibility of the patient's testimony, which may exacerbate certain vulnerabilities of the person in pain. However, misplaced trust in certain patients may render the physician vulnerable to the potential harms of POA. If patients distrust their physician, or feel distrusted by them, this may destabilise the therapeutic relationship and compromise care. A process of epistemic humility may help cultivate mutual patient-physician trust. Epistemic humility is a collaborative effort between physicians and patients that recognises the role of patients' subjective knowledge in enhancing physicians' self-understanding of their theoretical and practice frameworks, values and assumptions about the motivations of certain patients who report chronic pain.

摘要

处方阿片类药物滥用(POA)是一个日益严重的临床和公共卫生问题。在开具处方会带来专业和法律后果,进而营造出对慢性疼痛管理不信任氛围的背景下,医生担心医源性成瘾以及患者是否在“寻求药物”“滥用”和“转移”处方阿片类药物。规避这些担忧的一种尝试是使用阿片类药物合同,该合同概述了患者为获得阿片类药物必须同意的条件。阿片类药物合同受到了一些学术关注,信任和可信赖性被视为关键价值观和美德。然而,很少有文章对这种背景下的信任和可信赖性进行批判性阐述,特别是当对于它们在增强或损害医患关系方面的作用存在分歧时。本文认为,阿片类药物合同对医患信任构成了一种误导性的诉求。假设患者不可信可能会错误地损害患者证词的可信度,这可能会加剧疼痛患者的某些脆弱性。然而,对某些患者的信任错位可能会使医生容易受到处方阿片类药物滥用潜在危害的影响。如果患者不信任他们的医生,或者觉得被医生不信任,这可能会破坏治疗关系并影响护理。认知谦逊的过程可能有助于培养医患之间的相互信任。认知谦逊是医生和患者之间的一种合作努力,它认识到患者主观知识在增强医生对其理论和实践框架、价值观以及对某些报告慢性疼痛患者动机假设的自我理解方面的作用。

相似文献

1
What's trust got to do with it? Revisiting opioid contracts.信任与之有何关系?重新审视阿片类药物使用合同。
J Med Ethics. 2014 Oct;40(10):673-7. doi: 10.1136/medethics-2013-101320. Epub 2013 Sep 7.
2
Opioid contracts and random drug testing for people with chronic pain - think twice.阿片类药物合同和慢性疼痛患者的随机药物检测——三思而后行。
J Law Med Ethics. 2009 Winter;37(4):841-5. doi: 10.1111/j.1748-720X.2009.00455.x.
3
Universal precautions: a matter of mutual trust and responsibility.通用防护措施:关乎相互信任与责任。
Pain Med. 2006 Mar-Apr;7(2):210-1; author reply 212. doi: 10.1111/j.1526-4637.2006.00114.x.
4
A rose by any other name: pain contracts/agreements.换个名字的玫瑰:疼痛契约/协议。
Am J Bioeth. 2010 Nov;10(11):5-12. doi: 10.1080/15265161.2010.519425.
5
The physician's covenant with patients in pain.医生与疼痛患者的契约。
Am J Bioeth. 2010 Nov;10(11):23-4. doi: 10.1080/15265161.2010.520588.
6
Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties.慢性非恶性疼痛管理中的阿片类药物使用协议:目标与不确定性
Am J Med. 2006 Apr;119(4):292-6. doi: 10.1016/j.amjmed.2005.09.019.
7
You Present like a Drug Addict: Patient and Clinician Perspectives on Trust and Trustworthiness in Chronic Pain Management.你表现得像个瘾君子:患者与临床医生对慢性疼痛管理中信任及可信赖性的看法
Pain Med. 2016 Aug;17(8):1394-406. doi: 10.1093/pm/pnv083. Epub 2016 Jan 11.
8
Urine drug testing in chronic pain.尿液药物检测在慢性疼痛中的应用。
Pain Physician. 2011 Mar-Apr;14(2):123-43.
9
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.美国介入性疼痛医师学会(ASIPP)慢性非癌痛患者阿片类药物负责任处方指南:第 2 部分——指南。
Pain Physician. 2012 Jul;15(3 Suppl):S67-116.
10
Approaches to improve pain relief while minimizing opioid abuse liability.减轻阿片类药物滥用风险的同时改善疼痛缓解的方法。
J Pain. 2010 Jul;11(7):602-11. doi: 10.1016/j.jpain.2010.02.008. Epub 2010 May 4.

引用本文的文献

1
The Legal Landscape for Opioid Treatment Agreements.阿片类药物治疗协议的法律背景。
Milbank Q. 2024 Sep;102(3):632-668. doi: 10.1111/1468-0009.12699. Epub 2024 May 10.
2
Making Sense: Treating Patients with Opioid Use Disorder through the Lens of Game Theory.理解:从博弈论视角治疗阿片类物质使用障碍患者
J Community Hosp Intern Med Perspect. 2024 Jan 12;14(1):80-85. doi: 10.55729/2000-9666.1277. eCollection 2024.
3
Influence of patient trust in provider and health literacy on receipt of guideline-concordant chronic opioid therapy in HIV care settings.
患者对提供者的信任和健康素养对接受符合指南的慢性阿片类药物治疗在 HIV 护理环境中的影响。
J Opioid Manag. 2023 Sep-Oct;19(5):385-393. doi: 10.5055/jom.0812.
4
Patient symptom exaggeration is associated with communication effectiveness and trust.患者症状夸大与沟通效果和信任相关。
PEC Innov. 2022 May 10;1:100050. doi: 10.1016/j.pecinn.2022.100050. eCollection 2022 Dec.
5
Impact of Informed Consent and Education on Care Engagement After Opioid Initiation in the Veterans Health Administration.知情同意与教育对退伍军人健康管理局启动阿片类药物治疗后护理参与度的影响。
J Pain Res. 2022 May 25;15:1553-1562. doi: 10.2147/JPR.S317183. eCollection 2022.
6
Chronic Pain and Opioid Prescribing: Three Ways for Navigating Complexity at the Clinical‒Population Health Interface.慢性疼痛与阿片类药物处方:临床-人群健康界面复杂性的三种应对方法。
Am J Public Health. 2022 Feb;112(S1):S56-S65. doi: 10.2105/AJPH.2021.306500.
7
Scoping Review of the Literature on Smart Healthcare for Older Adults.老年人智能医疗保健文献的范围综述。
Yonsei Med J. 2022 Jan;63(Suppl):S14-S21. doi: 10.3349/ymj.2022.63.S14.
8
Switzerland's Narcotics Regulation Jungle: Off-Label Use, Counterfoil Prescriptions, and Opioid Agonist Therapy in the French-Speaking Cantons.瑞士麻醉药品监管丛林:法语区的标签外使用、副联处方和阿片类激动剂治疗。
Int J Environ Res Public Health. 2021 Dec 14;18(24):13164. doi: 10.3390/ijerph182413164.
9
Opioids for chronic pain management in patients with dialysis-dependent kidney failure.阿片类药物治疗透析依赖型肾衰竭患者慢性疼痛管理。
Nat Rev Nephrol. 2022 Feb;18(2):113-128. doi: 10.1038/s41581-021-00484-6. Epub 2021 Oct 7.
10
Barriers and facilitators encountered by family physicians prescribing opioids for chronic non-cancer pain: a qualitative study.家庭医生为慢性非癌性疼痛开具阿片类药物时遇到的障碍和促进因素:一项定性研究。
Health Promot Chronic Dis Prev Can. 2021 Jun;41(6):182-189. doi: 10.24095/hpcdp.41.6.03.